Laurence Suel

966 total citations
18 papers, 741 citations indexed

About

Laurence Suel is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Laurence Suel has authored 18 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Cell Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Laurence Suel's work include Muscle Physiology and Disorders (14 papers), Calpain Protease Function and Regulation (9 papers) and RNA regulation and disease (5 papers). Laurence Suel is often cited by papers focused on Muscle Physiology and Disorders (14 papers), Calpain Protease Function and Regulation (9 papers) and RNA regulation and disease (5 papers). Laurence Suel collaborates with scholars based in France, United Kingdom and United States. Laurence Suel's co-authors include Isabelle Richard, Carinne Roudaut, Nathalie Bourg, Marc Bartoli, J. Beckmann, Françoise Fougerousse, Muriel Durand, Karine Charton, Sylvie Marchand and Nathalie Danièle and has published in prestigious journals such as Circulation, Nature Communications and The Journal of Cell Biology.

In The Last Decade

Laurence Suel

18 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurence Suel France 16 652 258 166 162 94 18 741
Alice Steinbrecher Germany 5 638 1.0× 118 0.5× 125 0.8× 83 0.5× 93 1.0× 7 725
Edward Nylen Canada 12 800 1.2× 135 0.5× 229 1.4× 192 1.2× 76 0.8× 17 888
Francesco Muntoni United Kingdom 5 1.1k 1.8× 171 0.7× 85 0.5× 216 1.3× 71 0.8× 8 1.2k
Patrick Frosk Canada 10 495 0.8× 74 0.3× 119 0.7× 140 0.9× 81 0.9× 18 618
Burcu Balcı-Hayta Türkiye 10 383 0.6× 140 0.5× 75 0.5× 70 0.4× 50 0.5× 19 489
Nathalie Deburgrave France 13 461 0.7× 91 0.4× 149 0.9× 109 0.7× 91 1.0× 26 567
Svetlana Gorokhova France 9 409 0.6× 221 0.9× 101 0.6× 200 1.2× 53 0.6× 25 553
Karine Charton France 15 436 0.7× 90 0.3× 83 0.5× 175 1.1× 85 0.9× 19 485
Marie‐Aline Ludosky France 12 521 0.8× 163 0.6× 106 0.6× 121 0.7× 36 0.4× 15 632
Cécile Peccate France 15 560 0.9× 73 0.3× 59 0.4× 110 0.7× 112 1.2× 25 661

Countries citing papers authored by Laurence Suel

Since Specialization
Citations

This map shows the geographic impact of Laurence Suel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Suel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Suel more than expected).

Fields of papers citing papers by Laurence Suel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Suel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Suel. The network helps show where Laurence Suel may publish in the future.

Co-authorship network of co-authors of Laurence Suel

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Suel. A scholar is included among the top collaborators of Laurence Suel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Suel. Laurence Suel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Suel, Laurence, et al.. (2024). An engineered AAV targeting integrin alpha V beta 6 presents improved myotropism across species. Nature Communications. 15(1). 7965–7965. 10 indexed citations
2.
Amor, Fatima, Guillaume Corre, Laurence Suel, et al.. (2021). Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy. Journal of Cachexia Sarcopenia and Muscle. 12(3). 677–693. 36 indexed citations
3.
Massouridès, Emmanuelle, Nathalie Bourg, Laurence Suel, et al.. (2020). miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy. Scientific Reports. 10(1). 9139–9139. 20 indexed citations
4.
Lostal, William, Carinne Roudaut, Karine Charton, et al.. (2019). Titin splicing regulates cardiotoxicity associated with calpain 3 gene therapy for limb-girdle muscular dystrophy type 2A. Science Translational Medicine. 11(520). 22 indexed citations
5.
Charton, Karine, et al.. (2016). Exploiting the CRISPR/Cas9 system to study alternative splicingin vivo: application to titin. Human Molecular Genetics. 25(20). ddw280–ddw280. 19 indexed citations
6.
Charton, Karine, J. Sarparanta, Anna Vihola, et al.. (2015). CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy. Human Molecular Genetics. 24(13). 3718–3731. 36 indexed citations
7.
Bourg, Nathalie, Laurence Suel, Carinne Roudaut, et al.. (2014). Cis -splicing and Translation of the Pre- Trans -splicing Molecule Combine With Efficiency in Spliceosome-mediated RNA Trans -splicing. Molecular Therapy. 22(6). 1176–1187. 26 indexed citations
8.
Roudaut, Carinne, Florence Le Roy, Laurence Suel, et al.. (2013). Restriction of Calpain3 Expression to the Skeletal Muscle Prevents Cardiac Toxicity and Corrects Pathology in a Murine Model of Limb-Girdle Muscular Dystrophy. Circulation. 128(10). 1094–1104. 39 indexed citations
9.
Lostal, William, Marc Bartoli, Carinne Roudaut, et al.. (2012). Lack of Correlation between Outcomes of Membrane Repair Assay and Correction of Dystrophic Changes in Experimental Therapeutic Strategy in Dysferlinopathy. PLoS ONE. 7(5). e38036–e38036. 53 indexed citations
10.
Danièle, Nathalie, Laurence Suel, Sylvie Marchand, et al.. (2010). A new pathway encompassing calpain 3 and its newly identified substrate cardiac ankyrin repeat protein is involved in the regulation of the nuclear factor‐κB pathway in skeletal muscle. FEBS Journal. 277(20). 4322–4337. 41 indexed citations
11.
Suel, Laurence, Carinne Roudaut, Nathalie Bourg, et al.. (2008). Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling. FEBS Journal. 276(3). 669–684. 56 indexed citations
12.
Baghdiguian, Stephen, Marc Bartoli, Nathalie Danièle, et al.. (2007). NF‐NF ‐κ BB‐dependent expression of the antiapoptotic factor c‐FLIP is regulated by calpain 3, the protein involved in limb‐girdle muscular dystrophy type 2A. The FASEB Journal. 22(5). 1521–1529. 47 indexed citations
13.
Bartoli, Marc, Carinne Roudaut, Samia Martin, et al.. (2005). Safety and Efficacy of AAV-Mediated Calpain 3 Gene Transfer in a Mouse Model of Limb-Girdle Muscular Dystrophy Type 2A. Molecular Therapy. 13(2). 250–259. 57 indexed citations
14.
Fougerousse, Françoise, Muriel Durand, Soledad López, et al.. (2002). Six and Eya expression during human somitogenesis and MyoD gene family activation. Journal of Muscle Research and Cell Motility. 23(3). 255–264. 51 indexed citations
15.
Durand, Muriel, et al.. (2002). Sequential expression of genes involved in muscular dystrophies during human development.. PubMed. 86(273). 9–12. 6 indexed citations
16.
Fougerousse, Françoise, Louise V.B. Anderson, Anne‐Lise Delezoide, et al.. (2000). Calpain3 expression during human cardiogenesis. Neuromuscular Disorders. 10(4-5). 251–256. 21 indexed citations
17.
Richard, Isabelle, Carinne Roudaut, Sylvie Marchand, et al.. (2000). Loss of Calpain 3 Proteolytic Activity Leads to Muscular Dystrophy and to Apoptosis-Associated Iκbα/Nuclear Factor κb Pathway Perturbation in Mice. The Journal of Cell Biology. 151(7). 1583–1590. 147 indexed citations
18.
Fougerousse, Françoise, Muriel Durand, Laurence Suel, et al.. (1998). Expression of Genes (CAPN3, SGCA, SGCB, and TTN) Involved in Progressive Muscular Dystrophies during Early Human Development. Genomics. 48(2). 145–156. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice Steinbrecher Breakdown of academic impact, for papers by Edward Nylen Breakdown of academic impact, for papers by Francesco Muntoni Breakdown of academic impact, for papers by Patrick Frosk Breakdown of academic impact, for papers by Burcu Balcı-Hayta Breakdown of academic impact, for papers by Nathalie Deburgrave Breakdown of academic impact, for papers by Svetlana Gorokhova Breakdown of academic impact, for papers by Karine Charton Breakdown of academic impact, for papers by Marie‐Aline Ludosky Breakdown of academic impact, for papers by Cécile Peccate
Rankless by CCL
2026